1) Invasive pulmonary fungal infections
侵袭性肺部真菌感染
1.
The diagnosis of invasive pulmonary fungal infections, according to the criteria as defined by the European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MCS), is difficult to establish in organ transplant recipients.
近年来由于造血干细胞移植、实体器官移植的广泛开展、高强度免疫抑制剂和大剂量化疗药物的应用以及各种导管的体内介入、留置等,临床上侵袭性肺部真菌感染(invasive pulmonary fungal infections, IPFI)的发病率和死亡率明显上升,其中,最常见的是曲霉菌感染(invasive pulmonary aspergillosis, IPA)和白色念珠菌感染(invasive pulmonary candidiasis,IPC)。
2) invasive pulmonary fungal infection
侵袭性肺部真菌感染
1.
Objective: to analyze the results of identification and drug sensitive test of the fungi,and the proportion of pathogenic bacteria in respiratory system; To evaluate the status of the diagnosis and treatment of invasive pulmonary fungal infections; to study the risk factors of the invasive pulmonary fungal infections.
目的:调查呼吸道分离的真菌种类、耐药情况及在呼吸道检出病原菌中所占的比例;分析临床上侵袭性肺部真菌感染的诊断及治疗情况;探讨分析医院住院病人侵袭性肺部真菌感染的危险因素。
2.
Objective To summarize the clinical features of invasive pulmonary fungal infection(IPFI) secondary to malignant blood diseases(MBD).
目的总结恶性血液病患者继发侵袭性肺部真菌感染(IPFI)的临床特点。
3) invasive fungal infection
侵袭性真菌感染
1.
Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies;
47例恶性血液病患者侵袭性真菌感染的临床特点与治疗
2.
Clinical evaluation of voriconazole in malignant hematological disorders complicated by invasive fungal infection;
伏立康唑治疗恶性血液病合并侵袭性真菌感染20例临床分析
3.
Role of itraconazole in preventing invasive fungal infection;
伊曲康唑在侵袭性真菌感染中的预防作用
4) Invasive fungal infections
侵袭性真菌感染
1.
The combination therapy of amphotericin B with itraconazole or caspofungin in malignant hematologic diseases combined with invasive fungal infections;
两性霉素B联合伊曲康唑或卡泊芬净治疗恶性血液病并发侵袭性真菌感染
2.
Clinical study of caspofungin on treatment of 55 malignant hemopathic patients with invasive fungal infections.;
卡泊芬净治疗55例恶性血液病患者侵袭性真菌感染的安全性研究
3.
Clinical analysis of itraconazole in the treatment of 127 malignant hematological patients with invasive fungal infections;
伊曲康唑治疗恶性血液病合并侵袭性真菌感染127例临床分析
5) IFI
侵袭性真菌感染
1.
[Objective] To evaluate the efficacy and safety of itraconazloe in treating the invasive fugal infection(IFI) in ICU.
[目的]评估伊曲康唑治疗ICU中危重患者侵袭性真菌感染(IFI)的疗效及安全性。
6) Acute invasive fungal infections
急性侵袭性真菌感染
补充资料：播散性真菌感染
播散性真菌感染
创面真菌感染或系统性真菌感染发展，侵入体内血液、脏器，称播散性真菌感染。但是，血真菌培养阳性率低，培养阴性时不能除外播散性真菌感染。若要待血培养阳性或典型的败血症出现时才诊治，已为时过晚，常错失治疗时机。所以，临床上见创面真菌灶发展迅速，出现酷似绿脓杆菌败血症的早期症状时，就应及时诊断和治疗。创面、痂下组织、血、尿培养结果则可明确真菌的菌种，对选用抗真菌药物有用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条